← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL 10b5-1 Plan

$ Value

$101K

Shares

1,973

Price

$51

Filed

Aug 19

Insider

Name

Trimarchi Thomas

Title

President and CFO

CIK

0002030813

Roles

Officer

Transaction Details

Transaction Date

2025-08-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

463,318

Footnotes

Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units. | This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025. | Represents the weighted average sale price of the shares sold from $49.76 to $50.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $50.83 to $50.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Filing Info

Accession No.

0000950170-25-110274

Form Type

4

Issuer CIK

0001743881

Trimarchi Thomas's History

Date Ticker Type Value
2025-08-21 BBIO $2.1M
2025-08-18 BBIO $771K
2025-08-18 BBIO $101K
2025-08-16 BBIO F $1.1M
2025-05-16 BBIO F $721K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10